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Introduction 
 
From 18th May in the UK patients, health and social care staff, and the public could arrange their 
own COVID 19 tests directly through government phone line or website in the absence of proper 
clinical input and oversight. This is despite the Royal College of Pathologists highlighting how 
problems with testing arise because of lack of clinical input, and emphasising how people being 
tested need to be informed about why they are being tested and the meaning of their results (1). 
In late summer 2020, multiple media outlets reported demand for tests (predominantly in 
England) as exceeding the capacity of the system, leaving many unable to access testing. However 
this is not the only concern regarding the current UK testing system. These relate to contractual 
arrangements, lack of clinical integration, and use of results. A new strategy is required, with 
clinical input, clinical oversight and integration into local primary care and public health systems. 
 
Testing for covid-19 
There are currently two main types of testing; for acute infection (presence of virus, via throat 
swab) and past infection (antibody). Testing for acute infection is used to support clinical diagnosis 
and clinical management of suspected cases; to inform contact tracing and case finding; to 
monitor and support outbreak control including testing of asymptomatic people in high risk 
settings, for example prisons, schools, care homes and hospitals. Testing for antibodies indicates 
past infection and is currently used for research and surveillance purposes. However both have 
significant caveats. The PCR test is not a test of infectiousness (2). A positive result detects viral 
RNA fragment in the sample but does not distinguish between those who have the virus and are 
infectious, and symptomless people who may or may not be infectious.   The accuracy of testing in 
a real life population is unknown, but false negatives of up to 29% are reported (3). Because of 
this, clinical input is required to interpret, risk manage, and manage the results. This is essential to 
avoid false reassurance, leading to symptomatic people stopping isolation on the basis of a false 
negative test, risking spreading infection. Without clinical input, a risk based, clinically judged 
approach to the use of a negative result is lacking. Moreover, there is no reference to potential 
false negatives in NHS website advice, which currently reads:' a negative result means the test did 
not find coronavirus’ (4). There are still significant unknowns in regard to the real-life false 
negative rate in the community (5) The antibody test must also be carefully interpreted. A positive 
antibody test finds antibodies, but evidence as to whether this gives meaningful immunity or stops 
the spread of infection (6) is lacking. Additionally, there are ethical issues in the testing of 
asymptomatic people which require evidence-based information and consent. This, so far, appears 
to have been largely overlooked. 
 
 
 
Testing in the UK was initially limited to hospital admissions and has been expanded across the 
population (Box 1). However, tests have been beset by problems over purpose, concerns about 
the quality, accuracy and relevance of published test data and reporting of test results (7,8).  
 
Box 1 - Timeline of different routes to and eligibility for testing  
● 12th March: PCR testing of symptomatic people in the community and contact tracing ends as strategy moves 
from ‘contain’ to ‘delay’ (9). Deputy CMO Jenny Harries told the health select committee on 5th May that this 
decision was related to capacity in the testing system (10). Testing now only performed for patients in hospital 
across the UK 
● 27th March: plans to start testing symptomatic NHS staff in England announced (11) 
● 2nd April: target set to do 100k tests/day in England (including antibody tests), prioritising hospital patients, 
NHS staff and then other key workers (12).  
● 23th April: key workers invited to apply for PCR tests through their employers, and from 24th April can self-
refer (13). 
● 28th April: All patients over 70 screened in Scottish hospitals (14) 
● 28th April (England)(15) and 1st May (Scotland) (16): people over 65 and those who must leave home to work, 
as well as those they live with, are able to get tested if they have symptoms of the virus.  
● 18th May: Anyone in UK with symptoms able to apply for a test online or by telephone (17) 
● 27th May: Test and Trace launched across England (18) 
● 28th May: Test and Protect launched in Scotland (19) 
● 30th July: Plans set out to expand UK’s testing capacity to 500,000 tests a day over next 6 months (20) 
 
Care homes 
● PCR Testing in care homes for outbreaks only (first 5 residents with symptoms are tested), until 15th April in 
England when all symptomatic residents were eligible for tests and those being discharged from hospital into 
care homes were required to have a test (21) (result did not have to be back before discharge (22)) Scotland 
followed on 21st April (23). 
● 28th April: testing offered for all care home residents and staff in England, whether they have symptoms or not 
(24) 
● 1st May: enhanced outbreak testing in Scottish care homes - whole home tested if there is a confirmed case 
and sampling of care home residents and staff where there are no cases (25) 
● 11th May: all staff and residents in elderly care homes in England to be offered tests by 6th June, on a 
repeating basis (26) 
● 18th May: routine testing of care home staff on a repeating basis, regardless of whether symptomatic, in 
Scotland. (27) 
● 8th June: all UK adult care homes to be offered whole home testing (28) 
● 3rd July: UK plans announced for all care home staff to be tested weekly, and residents monthly (29) 
 
 
 
 
Testing is only of value when it is part of a complete system which is capable of reducing the 
burden of coronavirus.  
 
Lack of clinical integration  
 
One of the key failures in responding to the epidemic was the government’s  decision to take 
testing out of public health services and local authorities. Normally, testing is done via a health 
professional whose role is in clinical assessment, advice regarding testing, interpretation and then 
explanation of the results, together with undertaking statutory notification. A test is simply a 
diagnostic tool.  Because the current PCR COVID test is not a test of infectiousness, it cannot 
distinguish between those who have the virus and capable of infecting others, and those who have 
remnants of the virus but are not infectious. Clinical interpretation is therefore important for 
advice and diagnosis. In setting up a parallel testing system in the private sector, local public 
 
 
health departments and primary care were separated from the testing system. As a result the 
statutory notification system for reporting suspected cases was not followed. This resulted in poor 
community data which is likely to have delayed outbreak control.   
 
An optimal system would ensure access to evidence-based advice and testing, reliable, rapid 
laboratory analysis, swift reporting of results, professionally guided interpretation of results in the 
context of clinical symptoms, and advice on the limitations of testing. This needs to be followed by 
contact tracing, isolation advice, and the material, medical and mental health support to do so.  
 
Many GPs have complained of their inability to request covid-19 PCR swabs in practice, having to 
refer patients to centralised testing sites. It is important to note that the four nations have gone in 
different directions with regard to testing and integration with local public health teams. Results 
on tests, initially not delivered to GPs at all, now arrive without enough information for 
interpretation or for epidemiological purposes, lacking information on reason for testing, or risk 
factors.  
 
The UK Government strategy for testing, published 2nd April, is to support the development of a 
UK diagnostics industry (pillar 5) by expanding commercial testing for PCR and antibody tests 
through pillars 2,3 and 4. These tests are delivered by Thermo Fisher Scientific, Amazon, Boots, 
Royal Mail and Randox, alongside the Wellcome Trust, Lighthouse labs and some universities (see 
appendix 1– for online version). However, these test results may not all have been notified by the 
laboratories (30), have not been integrated with primary care nor do they provide real time data 
to local authorities (31).  
 
Patient and community outcomes  
 
 
Positive results should be seamlessly co-ordinated by a public health response and clinical input as 
needed from primary care. However, in England public health directors have described how they 
have not been given enough real time patient information to enable contact tracing from pillar 2 
test sites. The disease notification system in England was amended in 2010 requiring laboratories 
to notify PHE of test results but there is no longer a requirement to notify directors of public 
health and their proper officers – this means data has not been flowing locally (32). Reports from 
local public health departments indicated that, despite the central government saying they had all 
the information they needed for contact tracing, detailed 6/7 digit postcode level data was not 
provided, limiting the effectiveness of their response (33). Moreover, the contact tracing services 
in England comprise a parallel system of centralized, privatised call handling centres run by Serco 
and Sital while health protection teams operating out of PHE handle the complex cases from 
institutional settings eg care homes and workplaces. The performance measures for Serco, Capita 
and those employed by NHS professionals have not been published. However test and trace data 
in August highlighted how the call handlers were reaching only 61% of contacts, compared with 
over 95% for the public health teams (34).  Less than a fifth of people intend or manage to follow 
test, trace and isolate advice, raising questions about how effective the current system for 
protecting individuals and the public is (35).  In a localised outbreak in north England, centralised 
contact tracing reached only 50% of close contacts (36) but once given adequate information on 
people with positive test results, local public health teams set up their own contact tracing teams, 
with the local Director of Public Health tweeting on 8/8/20 that “we are now managing to contact 
9/10 of the cases the national system could not contact.” (37). Mopping up the failures of the 
privatized system is expensive and diverts money from other local authority services. In England, 
 
 
Serco and Sitel’s contracts, which were set to expire on August 23rd, have been extended by a 
projected £528 million (38) to over £700 million.  
  
Despite the failings of this largely private, highly centralised NHS Test and Trace system, it has 
been reported that the government intends to scale up testing to deliver weekly tests for the 
whole population. Deloitte and a slew of commercial companies are being contracted to deliver 
them under Operation Moonshot, a plan to ramp up tests to 10 million a day, at a cost of 100 
billion pounds – 70% of the annual NHS budget for England. Ten million tests a day will generate 
10,000 people testing falsely positive a day and result in unnecessary isolation and hardship for 
them and their contacts. (2)  
 
The way forward  
Primary care services across the UK were excluded from management and care of covid patients at 
the start of the epidemic. They are currently dealing with radical changes to their way of working, 
implemented over a short period of time (39). As we move towards winter planning, a longer-term 
response is crucial and the reality of multimorbidity, the multiple symptoms of potential 
coronavirus, and the long term care of patients with protracted symptoms needs to be 
considered. This will require significant investment in primary care and local public health services 
and NHS labs. Diverting the highly resourced funding from the ineffective and privatised test and 
trace service to local services would avoid fragmentation created by private companies and 
restore and rebuild much needed capacity. McKinsey has been paid £560,000 by the government 
to conduct a review of the inefficient test and trace system (40); however, without local public 
health and general practice expertise, it will continue to be ineffective.  While the UK- wide testing 
programme is privatised and England’s tracing system is run by Serco and Sital, Wales and 
Scotland have opted for locally run contact tracing systems. We consider that equivalent funding 
managed by local public health and primary care would be, by virtue of expertise and local 
knowledge, be better able to expand services according to needs in response to the pandemic. 
Clinical, rather than corporate leadership would ensure that the complexity of testing was 
acknowledged and accounted for, while drawing on the integrated nature of local public health 
departments.  We call on the Westminster government to end privatisation of testing and to 
reinstate and invest in NHS primary care, public health, and NHS laboratory services, and redirect 
the resources from the current private testing programmes back into the local primary care, local 
NHS labs and local  public health sector, directed by clinically-led need and with clinical oversight.  
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